Status:
COMPLETED
Influence of Emotions on Decision-making in Parkinson's Disease
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Parkinson Disease
Eligibility:
All Genders
50-65 years
Phase:
NA
Brief Summary
Parkinson's disease mainly affects the dopaminergic neurons of the Substancia nigra, which project on the striatum. Neuronal death within this structure leads to a decrease in dopamine levels. Dopamin...
Detailed Description
Some research shows that positive emotional states are associated with greater self-confidence, greater optimism, and better regulation of our decision-making. The goal is to test whether positive emo...
Eligibility Criteria
Inclusion
- Inclusion Criteria for patients :
- Diagnosis of the disease carried out by a hospital doctor
- Stable treatment for two months minimum.
- Mini-Mental Parkinson \> 26
- Under dopaminergic treatment
- Exclusion Criteria for patients :
- other neurological or psychiatric antecedents
- anxio-depressive symptomatology
- delusional or psychotic state
- Inclusion Criteria for witnesses :
- matched in age and sex
- Vision and hearing normal or successfully corrected
- Understand the French language
- general level in the test standard
- Exclusion Criteria for witnesses :
- neurological or psychiatric diseases
- anxio-depressive symptomatology
Exclusion
Key Trial Info
Start Date :
February 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 20 2020
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03342339
Start Date
February 8 2018
End Date
February 20 2020
Last Update
January 19 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Grenoble Alpes
Grenoble, France
2
CHU de Saint Etienne
Saint-Etienne, France, 42055